로딩 중…
지수 로딩 중…
CapsoVision Inc. Common Stock
CV· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.17+8.97%
2026-08-03
Financials
Valuation Metrics
CapsoVision Inc. Common Stock's Market Cap is $358M. At end of 2025 it was $2.62B. Ranked #2919 of 3,112 in US market (top 94%), #1298 of 1,445 on NASDAQ (top 90%), #236 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 88%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $358M | US#2,919/3,112 Sec#236/269 |
| Revenue | $14M | US#2,918/3,112 Sec#178/269 |
| Net Income | $-27M | US—/3,112 Sec—/269 |
| Total Assets | $26M | US#3,059/3,112 Sec#270/269 |
| Net Assets | $20M | US#2,978/3,112 Sec#254/269 |
| Value | ||
| P/B | 17.72x | US#2,783/3,112 Sec#229/269 |
| P/S | 26.41x | US#2,842/3,112 Sec#155/269 |
| FCF Yield | -6.71% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -133.40% | US#2,882/3,112 Sec#230/269 |
| Op. Margin | -11.01% | US#2,641/3,112 Sec#100/269 |
| Revenue Growth | 0.32% | US#2,207/3,112 Sec#125/269 |
| Financial Health | ||
| Debt Ratio | 28.31% | US#305/3,112 Sec#101/269 |
| Total Debt | $788000.00 | US#2,938/3,112 Sec#249/269 |
| FCF | $-24M | US#2,386/3,112 Sec#96/269 |
| Cash | $18M | US#2,885/3,112 Sec#262/269 |
| Current Ratio | 4.57x | US#528/3,112 Sec#159/269 |
| Performance | ||
| 1Y Return | 83.38% | US#449/3,112 Sec#97/269 |
| 1M Return | -1.51% | US#1,861/3,112 Sec#94/269 |
| From 52W High | -53.35% | US#2,841/3,112 Sec#226/269 |
| 1Y MDD | -67.82% | US#2,887/3,112 Sec#242/269 |
| Trading | ||
| Volume | 113,687 shares | US#2,900/3,112 Sec#262/269 |
| Trading Value | $799219.00 | US#3,045/3,112 Sec#260/269 |